Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 12;140(49):17197-17202.
doi: 10.1021/jacs.8b10076. Epub 2018 Nov 28.

Trimethylphosphate as a Methylating Agent for Cross Coupling: A Slow-Release Mechanism for the Methylation of Arylboronic Esters

Affiliations

Trimethylphosphate as a Methylating Agent for Cross Coupling: A Slow-Release Mechanism for the Methylation of Arylboronic Esters

Zhi-Tao He et al. J Am Chem Soc. .

Abstract

A methyl group on an arene, despite its small size, can have a profound influence on biologically active molecules. Typical methods to form a methylarene involve strong nucleophiles or strong and often toxic electrophiles. We report a strategy for a new, highly efficient, copper and iodide co-catalyzed methylation of aryl- and heteroarylboronic esters with the mild, nontoxic reagent trimethylphosphate, which has not been used previously in coupling reactions. We show that it reacts in all cases tested in yields that are higher than those of analogous copper-catalyzed reactions of MeOTs or MeI. The combination of C-H borylation and this methylation with trimethylphosphate provides a new approach to the functionalization of inert C-H bonds and is illustrated by late-stage methylation of four medicinally active compounds. In addition, reaction on a 200 mmol scale demonstrates reliability of this method. Mechanistic studies show that the reaction occurs by a slow release of methyl iodide by reaction of PO(OMe)3 with iodide catalyst, rather than the typical direct oxidative addition to a metal center. The low concentration of the reactive electrophile enables selective reaction with an arylcopper intermediate, rather than nucleophilic groups on the arylboronate, and binding of tert-butoxide to the boronate inhibits reaction of the electrophile with the tert-butoxide activator to form methyl ether.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1.
Scheme 1.. Research Design
Scheme 2.
Scheme 2.. Scope of Arylboronic Esters That Undergo Methylation with PO(OMe)3a
aConditions: 1 (1.0 equiv), PO(OMe)3 (1.1 equiv), CuI (5−10 mol %), LiI (20 mol%), LiOtBu (1.1 equiv), DMI (0.66M), 50 °C. Isolated yields are reported. For cases of MeOTs and MeI, yields were determined by crude 1H NMR or 19F NMR. bDetermined by crude 1H NMR.
Scheme 3.
Scheme 3.. Scope of Heteroarylboronic Esters That Undergo Methylation with PO(OMe)3a
aConditions: 3 (1.0 equiv), PO(OMe)3 (1.1 equiv), CuI (10 mol%), LiI (20 mol %), LiOtBu (1.1 equiv), DMI (0.66M), 50 °C. Isolated yields are reported. bReaction performed at 2 mmol scale. cCuI (20 mol%) was used.
Scheme 4.
Scheme 4.. Late-Stage Site-Selective C−H Methylation of Biologically Active Moleculesa
aSee SI for details.
Scheme 5.
Scheme 5.. Reaction with 200 mmol of Arylboronate
Scheme 6.
Scheme 6.. Stoichiometric Reactions Potentially Occurring in the Catalytic System
aReactivity comparison of MeI and PO(OMe)3 with ArCu. bMeI generation from PO(OMe)3 and LiI. cReaction of 4-FPhBpin with LiOtBu.
Scheme 7.
Scheme 7.. Kinetic Order of the Methylation Reaction
Scheme 8.
Scheme 8.. Proposed Reaction Mechanism

References

    1. Bazzini P; Wermuth CG Substituent Groups. The Practice of Medicinal Chemistry, 3rd ed.; Academic Press: New York, 2008; Chapter 20, pp 429–463.
    2. Barreiro EJ; Kummerle AE; Fraga CA Chem. Rev 2011, 111, 5215–5246. - PubMed
    3. Schönherr H; Cernak T Angew. Chem., Int. Ed 2013, 52, 12256–12267. - PubMed
    1. Anderson KE; Stamler D; Davis MD; Factor SA; Hauser RA; Isojärvi J; Jarskog LF; Jimenez-Shahed J; Kumar R; McEvoy JP; Ochudlo S; Ondo WG; Fernandez HH Lancet Psychiatry 2017, 4, 595–604. - PubMed
    1. Yan G; Borah AJ; Wang L; Yang M Adv. Synth. Catal 2015, 357, 1333–1350.
    1. Hall DG Boronic Acids: Preparation and Applications in Organic Synthesis and Medicine; Wiley-VCH: Weinheim, 2005; pp 1 – 99.
    1. Gooßen L Appl. Organomet. Chem 2004, 18, 602–604.
    2. Yang CT; Zhang ZQ; Liu YC; Liu L Angew. Chem., Int. Ed 2011, 50, 3904–3907. - PubMed

Publication types